维普中文期刊产品整合服务
26篇 您的检索式:作者名="LoRusso P M"
    题名 作者 年代 出处 被引量
1Tremelimumab in combination with exemestane in patients with advanced breast cancer and treatment-associated modulation of inducible costimulator expression on patient T cells 显示文摘Vonderheide R H LoRusso P M Khalil M 2010Cancer Res2010,16,13:1
2Dermatologic side effects associated with gefitinib therapy:clinical experience and management显示文摘HERBST R S LORUSSO P M PURDOM M 2003Clin Lung Cancer2003,4,6:1
3Haemodynamic effects of intravenous growth hormone kin congestive heart failure显示文摘Volterrani M Desenzani P Lorusso R 1997Lancet1997,349,4:1
4Improvements in quality of life and disease-related symptoms in phase Ⅰ trials of the selective oral epidermal growth factor receptor tyrosine inhibitor ZD1839 in non-small-cell lung cancer and other solid tumors显示文摘Lorusso P M Herbst R S Rischin D 2003Clin Cancer Res2003,9,6:1
5A Phase Ib study evaluating MNRP1685A, a fully human anti-NRP1 mono- clonal antibody, in combination with bevacizumab and paelitaxel in patients with advanced solid tumors 显示文摘Patnaik A LoRusso P M Messersmith W A 2014Cancer Chemother Phar- macol2014,73,5:1
6Improvements in quality of life and disease--related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinases inhibitor ZD1839 in non small cell lung cancer and other solid tumor显示文摘Lorusso P M Herbst R S Rischin D 2003Clin Cancer Res2003,9,6:1
7Inhibition of the hedgehog pathway in advanced basal-cell carcinoma 显示文摘VON HOFF D D LORUSSO P M RUDIN C M 2009N Engl J Med2009,361,12:1
8Inhibition of the hedgehog pathway in advanced basal-cell carcinoma显示文摘Von Hoff D D LoRusso P M Rudin C M 2009New England Journal of Medicine2009,361,12:1
9Haemodynamic effects of intravenous growth hormone in congestive heart failure 显示文摘 Desenzani P Lorusso R 1997Lancet,1997;349:10671997,349,:1
10Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase in- hibitor ZD1839 in non-small cell lung cancer and other solid tumors 显示文摘LoRusso P M Herbst R S Rischin D 2003Clin Cancer Res2003,9,6:1
11Trastuzumab emtansine: a unique antibody-drug conjugate in development for human epidermal growth factor receptor 2-positive cancer 显示文摘LoRusso P M Weiss D Guardino E 2011Clin Cancer Res2011,17,20:1
12Trastu- zumab emtansine: a unique antibody-drug conjugate in development for human epidermal growth factor receptor 2- positive cancer显示文摘LORUSSO P M WEISS D GUARDINO E 2011Clin Cancer Rse2011,17,20:1
13Clinical im- plications of pathophysiological and demographic covariates on the population pharmacokinetics of trastuzumab emtansine, a HER2-targeted antibody-drug conjugate, in patients with HER2-positive metastatic breast cancer 显示文摘GUPTA M LORUSSO P M WANG B 2012J Clin Phat3naco12012,52,5:1
14Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126显示文摘Evelhoch J L LoRusso P M He Zhan-quan 2004Clin Cancer Res2004,10,11:1
15Vascular Disrupting Agents显示文摘Pilat M J LoRusso P M 2006J Cellular Biochem2006,99,:1
16Phase I studies of ZD1839 in patients with common solid tumors 显示文摘Lorusso P M 2003Semin Oncol2003,30,11:1
17Targeting the epidermal growth factor receptor显示文摘El-Rayes B F LoRusso P M 0,,03:1
18Spectral analysis of line width roughness and its apphcation to immersion lithography 显示文摘Lorusso G F Leunissen P Ercken M 2006Journal of Microlithography Microfabrication and Microsystems2006,5,3:1
19Phase 0 clinical trials: an answer to drug development stagnation?显示文摘LoRusso P M 2009J Clin Oncol2009,27,16:1
20Improvements in quality of life and disease-related symptoms in phase I trials of the selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in non-small cell lung cancer and other solid tumors显示文摘LoRusso P M Herbst R S Rischin D 2003Clin Cancer Res2003,9,6:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费